Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3689 (110th)

Ovarian Cancer Biomarker Research Act of 2007

referredUnited States· United States Congress· EN

Introduced

27 September 2007

Last action

8 November 2007 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Berman, Howard L. [D-CA-28], Rep. Hall, Ralph M. [R-TX-4], Rep. Burton, Dan [R-IN-5], Rep. Issa, Darrell [R-CA-48], Rep. Davis, Jo Ann [R-VA-1], Rep. Radanovich, George [R-CA-19], Rep. Wolf, Frank R. [R-VA-10], Rep. Lee, Barbara [D-CA-12], Rep. McDermott, Jim [D-WA-7], Rep. McNulty, Michael R. [D-NY-23], Rep. Tauscher, Ellen O. [D-CA-10], Rep. McCarthy, Carolyn [D-NY-4], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Farr, Sam [D-CA-20], Rep. Cleaver, Emanuel [D-MO-5], Rep. Weiner, Anthony D. [D-NY-9], Rep. Honda, Michael M. [D-CA-15], Rep. Murphy, Patrick J. [D-PA-8], Rep. Rush, Bobby L. [D-IL-1], Rep. Green, Gene [D-TX-29], Rep. Israel, Steve [D-NY-3], Rep. King, Peter T. [R-NY-2], Rep. Matsui, Doris O. [D-CA-7], Rep. Nadler, Jerrold [D-NY-12], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. DeGette, Diana [D-CO-1], Rep. Kind, Ron [D-WI-3], Rep. Barrow, John [D-GA-12], Rep. Cohen, Steve [D-TN-9], Rep. Price, David E. [D-NC-4], Rep. Boucher, Rick [D-VA-9], Rep. Sutton, Betty [D-OH-13], Rep. Bachus, Spencer [R-AL-6], Rep. Salazar, John T. [D-CO-3], Rep. Platts, Todd Russell [R-PA-19], Rep. Miller, George [D-CA-11], Sen. Markey, Edward J. [D-MA], Rep. Capps, Lois [D-CA-24], Rep. Clay, Wm. Lacy [D-MO-1], Rep. LaTourette, Steven C. [R-OH-14], Rep. Ross, Mike [D-AR-4], Rep. Ellison, Keith [D-MN-5], Rep. Baca, Joe [D-CA-43], Rep. Ferguson, Mike [R-NJ-7], Rep. Green, Al [D-TX-9], Rep. Lofgren, Zoe [D-CA-18], Rep. LoBiondo, Frank A. [R-NJ-2], Rep. Engel, Eliot L. [D-NY-16]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Summary

Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence. Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; and (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens. Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee to assist the Director to design and implement national clinical trials to determine the utility of such biomarkers; and (3) establish a national data center to conduct statistical analyses of trial data.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 27 September 2007

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 27 September 2007

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 27 September 2007

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 28 September 2007

    Introduced

    Sponsor introductory remarks on measure. (CR E2019-2020)

    Source: IntroReferral

  5. 8 November 2007

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 27 September 2007

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 27 September 2007

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 27 September 2007

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 99 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.